Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-BROMO-2-ETHOXYPYRIDINE is an organic compound characterized by the presence of a bromine atom at the 3rd position and an ethoxy group at the 2nd position on a pyridine ring. It is a significant intermediate in the synthesis of various chemical products due to its unique structural properties.

57883-25-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 57883-25-7 Structure
  • Basic information

    1. Product Name: 3-BROMO-2-ETHOXYPYRIDINE
    2. Synonyms: 3-BROMO-2-ETHOXYPYRIDINE;2-Ethoxy-3-Bromopyridine
    3. CAS NO:57883-25-7
    4. Molecular Formula: C7H8BrNO
    5. Molecular Weight: 202.04852
    6. EINECS: N/A
    7. Product Categories: Pyridine
    8. Mol File: 57883-25-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 210.307 °C at 760 mmHg
    3. Flash Point: 80.991 °C
    4. Appearance: yellow liquid
    5. Density: 1.45 g/cm3
    6. Vapor Pressure: 0.28mmHg at 25°C
    7. Refractive Index: 1.5450 to 1.5490
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. PKA: 1.68±0.22(Predicted)
    11. CAS DataBase Reference: 3-BROMO-2-ETHOXYPYRIDINE(CAS DataBase Reference)
    12. NIST Chemistry Reference: 3-BROMO-2-ETHOXYPYRIDINE(57883-25-7)
    13. EPA Substance Registry System: 3-BROMO-2-ETHOXYPYRIDINE(57883-25-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 57883-25-7(Hazardous Substances Data)

57883-25-7 Usage

Uses

Used in Agrochemical Industry:
3-BROMO-2-ETHOXYPYRIDINE is used as a key intermediate for the development of new agrochemicals, specifically in the creation of pesticides and other compounds that help protect crops from pests and diseases.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 3-BROMO-2-ETHOXYPYRIDINE serves as an essential building block for the synthesis of various drugs. Its unique structure allows for the development of molecules with specific therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Dye Industry:
3-BROMO-2-ETHOXYPYRIDINE is also utilized as an intermediate in the production of dyes. Its chemical structure enables the creation of dyes with specific color properties, making it a valuable component in the formulation of a wide range of colorants for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 57883-25-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,8,8 and 3 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 57883-25:
(7*5)+(6*7)+(5*8)+(4*8)+(3*3)+(2*2)+(1*5)=167
167 % 10 = 7
So 57883-25-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BrNO/c1-2-10-7-6(8)4-3-5-9-7/h3-5H,2H2,1H3

57883-25-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B4738)  3-Bromo-2-ethoxypyridine  >97.0%(GC)(T)

  • 57883-25-7

  • 1g

  • 1,200.00CNY

  • Detail
  • TCI America

  • (B4738)  3-Bromo-2-ethoxypyridine  >97.0%(GC)(T)

  • 57883-25-7

  • 5g

  • 4,250.00CNY

  • Detail
  • Alfa Aesar

  • (H27690)  3-Bromo-2-ethoxypyridine, 95%   

  • 57883-25-7

  • 250mg

  • 664.0CNY

  • Detail
  • Alfa Aesar

  • (H27690)  3-Bromo-2-ethoxypyridine, 95%   

  • 57883-25-7

  • 1g

  • 1529.0CNY

  • Detail

57883-25-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Bromo-2-ethoxypyridine

1.2 Other means of identification

Product number -
Other names Pyridine,3-bromo-2-ethoxy

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57883-25-7 SDS

57883-25-7Relevant articles and documents

Regioselective Amination or Alkoxylation of Halogenated Amino-, Thio- or Alkoxypyridines via Pyridyne Intermediates

Djukanovic, Dimitrije,Heinz, Benjamin,Idriess, Mohamed,Knochel, Paul,Martin, Benjamin,Siemens, Fiona

, (2021/11/26)

The treatment of 3-halopyridines (Cl, Br) bearing an R-substituent in position 2 (R = OEt, NEt2, N-piperidyl, or SEt) or in position 5 (R = OMe, OEt, SEt, NMe2, NEt2, or aryl) with KHMDS and an amine at 25 C for 12 hours in THF provided regioselectively 3

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

-

Page/Page column 136, (2019/07/19)

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

MACROCYCLES AS PDE1 INHIBITORS

-

Paragraph 0245; 0246, (2019/06/30)

The present invention provides macrocycles of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

-

Paragraph 0645-0646, (2019/07/10)

The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

-

Page/Page column 133, (2019/07/19)

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

-

Page/Page column 127, (2018/09/25)

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

SUBSTITUTED TRIAZOLOPYRIDINES

-

Page/Page column 75-76, (2015/01/06)

The present invention relates to substituted triazolopyridine compounds of general formula (I); in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.

SULFONAMIDE DERIVATIVES AND USE THEREOF AS VGSC INHIBITORS

-

Page/Page column 45, (2013/07/05)

The invention relates to new sulfonamide Nav1.7 inhibitors and pharmaceutically acceptable salts thereof, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. Nav1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.

TRIAZOLOPYRIDINE DERIVATIVES

-

Page/Page column 105, (2011/06/23)

The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of proliferative diseases, as well as to intermediate compounds useful in the preparation of said compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57883-25-7